Additional file 1 of Intracranial efficacy and safety of furmonertinib 160 mg with or without anti-angiogenic agent in advanced NSCLC patients with BM/LM as salvage therapy
收藏Figshare2024-08-13 更新2026-04-08 收录
下载链接：
https://springernature.figshare.com/articles/dataset/Additional_file_1_of_Intracranial_efficacy_and_safety_of_furmonertinib_160_mg_with_or_without_anti-angiogenic_agent_in_advanced_NSCLC_patients_with_BM_LM_as_salvage_therapy/26572870/1
下载链接
链接失效反馈官方服务：
资源简介：
Additional file 1: Supplementary Table 1. Treatment history and strategies for patients who achieved a long duration of intracranial response after furmonertinib 160mg with or without anti-angiogenic agent as salvage therapy.
提供机构：
Li, Junling; Hao, Xuezhi; Yang, Ke; Xing, Puyuan; Wang, Qi; Xu, Ziyi
创建时间：
2024-08-13
